Can you — should you — keep expanding at this pace?” “Yes, we can… and yes, we should…. We would be crazy not to.” ...

The Oregon Department of Justice on Wednesday sued three of the nation’s largest insulin makers, accusing them of working with pharmacy benefit managers to drive up the price of a drug that diabetics ...

Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that Express Scripts, one of ...

HERCESSI(TM) becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...

UnitedHealth (UNH) and Humana (HUM) lead in excessive prescription refills, which cost Medicare and patients $3B in 2021–2023. Read more here.

Excessive prescription refilling by mail-order pharmacies leaves piles of unneeded pills. “Every time, there are 15 extra pills.” ...

Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...

Dec 19 (Reuters) - The U.S. government on Friday announced pilot programs to start in 2026 and 2027 that are aimed at reducing out-of-pocket drug costs under the Medicare healthcare program for older ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. When HCA Healthcare, one ...

(The Center Square) – Michigan hospitals are systematically exploiting a program for low-income patients, according to a new report. Released by Hospital Spending Watch, the report examined how ...